Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Transgenic mice for screening compounds with therapeutic potential against pain, hyper-thyroidism or obesity. These transgenic mice over-express DREAM, a transcriptional repressor More
Novel glycated peptide and protein biomarkers for glycemic control, as well as a method to monitor glycemic control in diabetic patients More
Adrenomedullin peptides and antibodies, which would be useful in the development of a therapeutic or for diagnostics use More
The use of this technology could lead to improved diagnosis of individuals with early stage liver disease. More
The most desirable feature of this new compound is its ability to specifically inhibit O-GlcNAcase without targeting the related hexosaminidase A (HEX A) and hexoaminidase B (HEX B) enzymes. More
The technology provides methods for diagnosis and treatment of conditions such as cancer, diabetes, or other conditions that are influenced by AM levels. More
A mechanism for augmenting the immune response against HEV in infected individuals More
Diabetes mellitus, a metabolic disease caused by deficiency of insulin, displays a higher or lower level of glucose concentration in blood than normal range(80-120mg/dL). More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms More
This newly developed dose measuring technology comprises of a thin foil that dissolves readily in the mouth thereby administering the exact dosage of certain medications. More
Related Reports
Market Research Reports provided by reports.innovaro.com
Aug 2008 - 117 pages - $2,350
Mar 2011 - 23 pages - $250
Apr 2010 - 121 pages - $2,350
Aug 2007 - 87 pages - $1,999
Sep 2011 - 20 pages - $99
Sep 2011 - 59 pages - $99
Nov 2007 - 173 pages - $1,860
Feb 2010 - 62 pages - $1,040
Apr 2009 - 100 pages - $1,040
Oct 2009 - 98 pages - $1,040
Your selection
- Therapeutic target
- Metabolism del
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Anorexia
- Anti-oxidant
- Appetite
- Bulimia nervosa
- Cachexia
- Cirrhosis
- Diabetes type I
- Diabetes type II
- Diabetic complications
- Fabry's disease
- Gallbladder disorder (other)
- Gallstones
- Gaucher's disease
- Hepatic protectors
- Hepatic protectors
- Hypercholesterolemia
- Hyperparathyroidism
- Hypertriglyceridemia
- Liver cancer
- Liver disorders (other)
- Metabolic disorder (other)
- Mineral supplement
- Obesity
- Weight loss
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us